Head and Neck Cancer
The Centers for Disease Control and Prevention (CDC) recommends some adults ages 27 to 45 talk with their health care provider about the HPV vaccine.
Mayo Clinic researchers have found that a new, shorter treatment for patients with HPV-associated oropharynx cancer leads to excellent disease control and fewer side effects, compared to standard treatment.